Stay updated on PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.

Latest updates to the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to reflect the current status of the PC14586 study, including new enrollment details for the Phase 2 monotherapy and Phase 1b combination therapy portions, as well as the addition of new locations and contact information for study sites. The previous version's details about enrollment completion for certain phases have been removed.SummaryDifference10%
- Check12 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference0.6%
- Check41 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check55 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check62 days agoChange DetectedThe website has added numerous new contacts for medical professionals, including notable figures such as Anthony El-Khoueiry, MD, and Patricia LoRusso, MD, while removing the previous version's type of intervention and updating the revision from v2.13.3 to v2.14.0.SummaryDifference5%
Stay in the know with updates to PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.